Table 2 Frequency of subjects with alterated values of the explored variables in subjects with high BMI distinguished in stone formers and non-stone formers
From: Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects
Stone formers N (%) | Non-stone formers N (%) | |
|---|---|---|
Subject count | 45 | 445 |
Sex (M/F) | 18/27 | 137/308 |
BMI > 30 kg/m2 | 24 (53.3) | 233 (52.4) |
Total serum cholesterol >200 mg/dl | 27 (60) | 276 (62.1) |
Serum HDL <50 mg/dl in F or <40 mg/dl in M | 31 (68.9) | 339 (76.3) |
Serum triglycerides >150 mg/dl | 17 (37.7)‡ | 80 (17.9) |
Fasting serum glucose >100 mg/dl | 22 (48.8)* | 121 (27.2) |
Serum gGT > 24 U/I in F or >30 U/I in M | 19 (45.2) | 148 (36.5) |
Serum AST >30 U/I in F or >40 U/I in M | 7 (15.5)† | 28 (6.3) |
Serum ALT >35 U/I in F or >40 U/I in M | 11 (24.4) | 71 (16) |
Waist circumference >80 cm in F or >92 cm in M | 43 (95.6) | 426 (95.7) |
Subcutaneous abdominal tissue >4 cm | 10 (22.2) | 99 (22.9) |
Visceral abdominal tissue >4 cm | 40 (88.9) | 346 (77.8) |
Systolic blood pressure >130 mmHg | 16 (35.5) | 134 (30.1) |
Diastolic blood pressure >85 mmHg | 13 (28.9) | 84 (18.9) |
MedDiet score ≥ 9 | 8 (17.8) | 67 (15.1) |